Target intelligence / Profile preview

Periodontopathogenic oral bacteria

Molecular classification
Bacteria, Pathogen
01

Overview

Periodontopathogenic oral bacteria are a specialized group of microorganisms, primarily anaerobic Gram-negative species, that reside in the subgingival biofilm and drive the progression of periodontal diseases. The most clinically significant group is the "Red Complex," which includes Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola, all of which are strongly correlated with severe tissue destruction (Socransky et al., 1998, Journal of Clinical Periodontology). These bacteria utilize virulence factors like gingipains and lipopolysaccharides to degrade the extracellular matrix and subvert the host immune response, leading to chronic inflammation (Hajishengallis, 2015, Nature Reviews Immunology). Treatment strategies focus on reducing the bacterial load through mechanical debridement and the use of antibiotics such as metronidazole or tetracyclines, which target essential bacterial processes like DNA replication and protein synthesis (Slots, 2017, Periodontology 2000). Furthermore, these pathogens are implicated in systemic health issues, as their presence in the bloodstream can exacerbate conditions like atherosclerosis and diabetes (Pihlstrom et al., 2005, The Lancet).

Other names
Periodontal pathogensRed complex bacteriaPeriodontopathic bacteriaOral pathogens
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis via 30S ribosomal subunit binding, and disruption of DNA integrity.

03

Biological functions

Biofilm formationProteolysisImmune evasionTissue degradation
04

Disease associations

InfectionInflammationPeriodontitisCardiovascular diseaseDiabetes mellitus
05

Safety considerations

Antimicrobial resistanceOral and systemic dysbiosisHypersensitivity reactionsGastrointestinal distress
06

Interacting drugs

Amoxicillin

5 more in the full profile.

07

Biomarkers

Probing pocket depth (PPD)Clinical attachment loss (CAL)Bleeding on probing (BOP)16S rRNA microbial profiling

Beyond the preview

Go deeper on Periodontopathogenic oral bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Periodontopathogenic oral bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call